What Does Non-Invasive Prenatal Testing (NIPT) Screen For? Key Insights

Learn what non-invasive prenatal testing (NIPT) detects, including Down syndrome and other chromosomal abnormalities with high accuracy and low risk.

57 views

Non-invasive prenatal testing (NIPT) tests for chromosomal abnormalities in a fetus, including conditions like Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). It analyzes small fragments of fetal DNA found in the mother's blood. NIPT is known for its high accuracy and low risk, making it a preferred choice for many expecting parents for early genetic screening.

FAQs & Answers

  1. What conditions does non-invasive prenatal testing detect? Non-invasive prenatal testing (NIPT) primarily detects chromosomal abnormalities such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13) by analyzing fetal DNA in the mother's blood.
  2. How accurate is non-invasive prenatal testing? NIPT is highly accurate for detecting major chromosomal abnormalities with a low false positive rate, making it a reliable early screening option during pregnancy.
  3. Is non-invasive prenatal testing safe for the mother and baby? Yes, NIPT is considered safe because it only requires a blood sample from the mother and poses no risk to the fetus, unlike invasive procedures such as amniocentesis.
  4. When is the best time to take non-invasive prenatal testing? NIPT can typically be performed as early as 10 weeks into pregnancy, allowing early detection of chromosomal abnormalities.